These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6458131)

  • 1. Donor-specific decreased primary and secondary cell-mediated immune responses in patients with well functioning grafts.
    Pfeffer PF; Hirschberg H; Thorsby E
    Transplant Proc; 1981 Sep; 13(3):1604-6. PubMed ID: 6458131
    [No Abstract]   [Full Text] [Related]  

  • 2. A functional assay of HLA-directed non-T-cell mediated lympholysis (CML).
    Goeken NE; Thompson JS
    Transplant Proc; 1978 Dec; 10(4):943-6. PubMed ID: 153620
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 4. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
    Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O
    Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor specific cell-mediated lympholysis (CML) by peripheral blood lymphocytes (PBL) from recipients with long-term renal grafts.
    Imai T; Takasaki E; Beck Y; Inoue S; Tseng CC; Sugimoto H; Nagao T; Akiyama N; Uchida H
    Transplant Proc; 1992 Aug; 24(4):1424-6. PubMed ID: 1386698
    [No Abstract]   [Full Text] [Related]  

  • 7. Retention of DR-specific memory in primed lymphocytes grown in PHA-conditioned media.
    Brown S; Maca R; Klassen L; Goeken N; Severson C; Thompson J
    Transplant Proc; 1979 Dec; 11(4):1982-5. PubMed ID: 93819
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants.
    Lazda VA; Jonasson O; Mozes MF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-immunologic problems in kidney transplantation].
    Lanzer G
    Wien Med Wochenschr; 1981; 131(6):139-43. PubMed ID: 6455015
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for suppressor cells and reduced CML induction by the donor in transplant patients.
    Liburd EM; Pazderka V; Kovithavongs T; Dossetor JB
    Transplant Proc; 1978 Sep; 10(3):557-61. PubMed ID: 152490
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor-specific CML hyporesponsiveness after successful renal transplantation: studies on the mechanism.
    Thomas JM; Thomas FT; Hoffman S; Johns C; Mendez-Picon G; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1258-9. PubMed ID: 157568
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated lympholysis: target susceptibility to lysis correlates with surface major histocompatibility complex expression.
    Suranyi MG; Waugh J; Bishop GA; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):417-20. PubMed ID: 2950620
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary cell-mediated lympholysis in man.
    Singal DP; Wadia YJ; Naipaul N
    Transplant Proc; 1978 Dec; 10(4):929-31. PubMed ID: 83726
    [No Abstract]   [Full Text] [Related]  

  • 14. Pretransplant immunologic reactivity to donor lymphocytes--lack of correlation with posttransplant events.
    Keown PA; Stiller CR; Bloch M; Sinclair NR; Lockwood BA; Howson WH
    Transplant Proc; 1981 Sep; 13(3):1563-4. PubMed ID: 7029815
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a suppressor cell system in human kidney allograft tolerance.
    Charpentier B; Lang P; Martin B; Fries D
    Transplant Proc; 1981 Mar; 13(1 Pt 1):90-4. PubMed ID: 6455811
    [No Abstract]   [Full Text] [Related]  

  • 16. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cell-mediated lympholysis in human foetal blood lymphocytes.
    Rayfield LS; Brent L; Rodeck CH
    Clin Exp Immunol; 1980 Dec; 42(3):561-70. PubMed ID: 6452236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of HLA in T-cell immune responses.
    Thorsby E; Bergholtz B; Berle E; Braathen L; Hirschberg H
    Transplant Proc; 1981 Mar; 13(1 Pt 2):903-8. PubMed ID: 6455828
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific suppressor T cells in a renal transplant recipient with a well-functioning kidney.
    Okimoto T; Yahata H; Fukuda Y; Hayamizu K; Shimatani K; Dohi K
    Transplant Proc; 1994 Apr; 26(2):858-60. PubMed ID: 8171687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.